TAM
NVO

Titleist Asset Management’s Novo Nordisk NVO Stock Holding History

Titleist Asset Management’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-2,815
Closed -$242K – 318
2024
Q4 		$242K Sell
2,815
-208
-7% -$22.5K 0.03% 278
2024
Q3 		$360K Sell
3,023
-618
-17% -$82.4K 0.05% 204
2024
Q2 		$520K Sell
3,641
-125
-3% -$16.6K 0.08% 163
2024
Q1 		$484K Sell
3,766
-126
-3% -$15K 0.08% 155
2023
Q4 		$403K Buy
3,892
+171
+5% +$16.9K 0.07% 158
2023
Q3 		$338K Sell
3,721
-255
-6% -$22.5K 0.07% 160
2023
Q2 		$322K Sell
3,976
-4
-0.1% -$327 0.06% 171
2023
Q1 		$317K Buy
+3,980
New +$282K 0.07% 164

Other funds holding NVO

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
TIM
Thornburg Investment Management Santa Fe, New Mexico $9.63B AUM 35.65% 1-Year Est. Return

Titleist Asset Management's NVO Position: Q1 2025 in Review

Titleist Asset Management sold out of Novo Nordisk (NVO) in Q1 2025, closing a stake of 2,815 shares — an estimated $242K sold.

Titleist Asset Management first reported a position in NVO in Q1 2023 and held it in 8 quarters. The position peaked at $520K in Q2 2024. 1,528 funds tracked by Wall St. Rank hold NVO as of Q1 2025.

  • Titleist Asset Management reported no remaining Novo Nordisk position as of Q1 2025 after selling out during the quarter.
  • Titleist Asset Management sold 2,815 Novo Nordisk shares in Q1 2025, an estimated $242K.
  • Titleist Asset Management first reported a position in Novo Nordisk in Q1 2023 and held it in 8 quarters.
  • Titleist Asset Management's Novo Nordisk position peaked at $520K in Q2 2024.
  • 1,528 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2025.

Based on Titleist Asset Management's 13F filing for Q1 2025, filed 15 May 2025.